BMO Capital resumes TransAlta stock coverage with outperform rating

BMO Capital resumed coverage on TransAlta with an Outperform rating and a $25.00 price target, highlighting the stock as attractive at about 9.5x 2027 estimated EBITDA versus 11.6x for its broader coverage universe. The $1 billion Colorado gas power acquisition has pressured shares nearly 12% over the past week, but the analyst says it supports long-term dividend and free cash flow sustainability. TransAlta also completed a $350 million share offering to help fund the purchase of two 318 MW natural gas peaking facilities in Colorado.

Analysis

The market is treating the Colorado acquisition as a balance-sheet event, but the more important implication is strategic optionality: TransAlta is buying a scarce entry point into firm peaking capacity in a region where power demand can reprice quickly with data-center growth and weather-driven load spikes. In that setup, the asset’s value is less about today’s EBITDA and more about the embedded call option on tightening capacity and corridor expansion into adjacent markets over the next 12-36 months.

The near-term downside is likely more about sentiment than fundamentals. The equity raise removes some financing risk, but it also caps upside until investors see integration discipline and no further equity-funded growth; that makes the next two quarters a credibility test for management rather than a pure operating story. If Alberta power prices soften or Colorado merchant power normalizes, the valuation debate could stay overhang-heavy despite the long-duration FCF case.

The broader second-order effect is that this transaction may force a re-rating gap between regulated/contracted power owners and merchant-heavy peers: capital will likely migrate toward names with incremental capacity, data-center adjacency, or hedged cash flows. The contrarian miss is that the market may be underestimating how quickly power scarcity can reprice in supply-constrained western grids; if load growth persists, what looks like a rich purchase today can become an accretive foothold within 1-2 years, especially if replacement costs rise faster than contract renewals.

This is still a stock-specific catalyst, not a sector-wide one: the move should be judged over months, not days. The cleanest tell will be whether management can use the deal to de-risk guidance and reinforce dividend durability without signaling another dilutive acquisition cycle.

Key Decisions for Investors

• Go long TAC on weakness over the next 1-3 weeks, targeting a 6-10% rebound if the market shifts from 'price paid' to 'cash flow durability'; use a tight stop if post-deal integration commentary turns defensive.
• Pair trade: long TAC / short a merchant-heavy North American power name over 1-3 months, expressing the view that scarce peaking capacity and dividend support deserve a premium while pure spot exposure remains vulnerable to normalization.
• Sell downside protection on TAC only after the next earnings/management update confirms no incremental dilution risk; the implied volatility should compress if the market gets comfort on financing and integration.
• Watch for a catalyst-driven add on any confirmation of Colorado load growth or incremental contracted offtake; that would extend the thesis from a valuation repair trade into a multi-quarter re-rating.